What is Johnson & Johnson's other oncology — percent change (as a percent)?

Johnson & Johnson (JNJ) reported other oncology — percent change (as a percent) of 42.1% in Q3 2025.

How has Johnson & Johnson's other oncology — percent change (as a percent) changed year-over-year?

Johnson & Johnson's other oncology — percent change (as a percent) increased by 180.2% year-over-year, from -52.5% to 42.1%.

What does other oncology — percent change (as a percent) mean?

The percentage growth rate of net sales for the secondary oncology product category compared to the previous period.

Other Oncology — Percent Change (as a percent)

Products & Services · Percent Change (as a percent)

Johnson & Johnson Other Oncology — Percent Change (as a percent) increased by 5.5% to 42.1% in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 180.2%, from -52.5% to 42.1%. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityVolatile

First reportedQ1 2018

Last reportedQ3 2025

How to read this metric

A positive percentage indicates accelerating demand or successful commercial execution, whereas a negative percentage suggests slowing market adoption or competitive pressure.

Detailed definition

This metric measures the period-over-period percentage growth or decline in net sales for the 'Other Oncology' product c...

Peer comparison

Comparable to year-over-year or sequential revenue growth rates for specific therapeutic sub-segments reported by other large-cap biopharmaceutical companies.

Metric ID: jnj_segment_other_oncology_percent_change_as_a_percent

Historical Data

14 periods

	Q2 '21	Q3 '21	Q4 '21	Q2 '22	Q3 '22	Q4 '22	Q2 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25
Value	-34.6%	-69.3%	-36%	-19.7%	-18.2%	-9%	20.2%	74.1%	73.8%	-52.5%	4.2%	69.2%	39.9%	42.1%
QoQ Change	—	-100.3%	+48.1%	+45.3%	+7.6%	+50.5%	+324.4%	+266.8%	-0.4%	-171.1%	+108.0%	>999%	-42.3%	+5.5%
YoY Change	—	—	—	+43.1%	+73.7%	+75.0%	+202.5%	—	+265.3%	—	—	-6.6%	-45.9%	+180.2%

Range-69.3% – 74.1%

CAGR+6.2%

Avg YoY Growth+98.4%

Median YoY Growth+74.4%

Similar Metrics at Other Companies

Eli LillyLLY View metric

Frequently Asked Questions

What is Johnson & Johnson's other oncology — percent change (as a percent)?: Johnson & Johnson (JNJ) reported other oncology — percent change (as a percent) of 42.1% in Q3 2025.
How has Johnson & Johnson's other oncology — percent change (as a percent) changed year-over-year?: Johnson & Johnson's other oncology — percent change (as a percent) increased by 180.2% year-over-year, from -52.5% to 42.1%.
What does other oncology — percent change (as a percent) mean?: The percentage growth rate of net sales for the secondary oncology product category compared to the previous period.